BioCentury
ARTICLE | Company News

Genesis Biopharma, SciMeDent Health Corp. deal

December 6, 2010 8:00 AM UTC

SciMeDent (formerly Trend Exploration Inc.) and Genesis mutually terminated a proposed deal granting SciMeDent exclusive, worldwide rights to R-954 to treat painful diabetic neuropathy after SciMeDent...